Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11774726 | 0.98 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL7061249 | 0.98 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL10409035 | 0.98 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL530161 | 0.94 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| Acrylic Acid SCHEMBL27993445 | 0.91 | TSHR (0.50) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL33780 | 0.86 | THRB (0.52) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL5144090 | 0.84 | TSHR (0.79) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL25426 | 0.84 | TSHR (0.79) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL28008586 | 0.84 | TSHR (0.42) | TSHRTHRBPOLBAPEX1HTT | |
| Acetic Acid SCHEMBL28158415 | 0.83 | THRB (0.48) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060121387-A1 | Toner processes | XEROX CORPORATION | 2006-06-08 | — | — | US | claimed |
| US-6664017-B1 | Document security processes | XEROX CORPORATION | 2003-12-16 | — | — | US | claimed |
| US-5385803-A | Authentication process | XEROX CORPORATION (US) | 1995-01-31 | — | — | US | claimed |
| US-5334471-A | Free-flowing toner comprising a mixture of shell-core polymers , low remanence magnetite and light scattering component | XEROX CORPORATION (US) | 1994-08-02 | — | — | US | claimed |
| US-5304448-A | Encapsulated toner compositions | XEROX CORPORATION (US) | 1994-04-19 | — | — | US | claimed |
| US-5223370-A | Low gloss toner compositions and processes thereof | XEROX CORPORATION (US) | 1993-06-29 | — | — | US | claimed |
| US-5215855-A | Encapsulated toner compositions | XEROX CORPORATION (US) | 1993-06-01 | — | — | US | claimed |
| US-5204208-A | Mixing at least two toners of different dyes or pigments | XEROX CORPORATION (US) | 1993-04-20 | — | — | US | claimed |
| US-5175071-A | Encapsulated toner composition | XEROX CORPORATION (US) | 1992-12-29 | — | — | US | claimed |
| US-5153089-A | Encapsulated toner compositions and processes thereof | XEROX CORPORATION (US) | 1992-10-06 | — | — | US | claimed |
| US-5153093-A | Overcoated encapsulated toner compositions and processes thereof | XEROX CORPORATION (US) | 1992-10-06 | — | — | US | claimed |
| US-5147744-A | MICR processes with colored encapsulated compositions | XEROX CORPORATION (US) | 1992-09-15 | — | — | US | claimed |
| US-5135832-A | COLORED TONER COMPOSITIONS | XEROX CORPORATION (US) | 1992-08-04 | — | — | US | claimed |
| US-5114819-A | Magnetic encapsulated toner compositions | XEROX CORPORATION (US) | 1992-05-19 | — | — | US | claimed |
| US-5082757-A | Encapsulated toner compositions | XEROX CORPORATION (US) | 1992-01-21 | — | — | US | claimed |
| US-5080986-A | Magnetic image character recognition processes with encapsulated toners | XEROX CORPORATION (US) | 1992-01-14 | — | — | US | claimed |
| US-5077167-A | Encapsulated toner compositions | XEROX CORPORATION (US) | 1991-12-31 | — | — | US | claimed |
| US-12597609-B2 | Positive electrode plate, secondary battery and power consuming device | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2026-04-07 | — | — | US | disclosed |
| US-4942906-A | FOR FUEL TRANSPORTATION | TOKAI RUBBER INDUSTRIES, LTD. (JP) | 1990-07-24 | — | — | US | disclosed |
| US-4021397-A | LATEX, HYDROXYLAMINE SULFATE | THE B. F. GOODRICH COMPANY (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12597609-B2 | Positive electrode plate, secondary battery and power consuming device | SCO2, CACNA2D4, CACNA2D1 | TSHR 2946/4885THRB 1304/4885POLB 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.